Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
LumiraDx
MedTech
Roche to pick up LumiraDx point-of-care tests through $350M deal
Roche aims to gain a selection of products from the flagging LumiraDx, including a shoebox-sized analyzer and a menu of specialized tests.
Conor Hale
Jan 2, 2024 11:52am
NIH deals out $77M to develop 12 new rapid COVID tests
Oct 15, 2021 11:23am
LumiraDx begins U.S. rollout of COVID-19 surveillance test
Sep 3, 2021 11:45am
COVID test drought leads LumiraDx to cut $2B off SPAC deal value
Aug 20, 2021 11:36am
CVS Health launches $100M digital health-focused venture fund
Apr 29, 2021 12:09pm
British pharmacy chain sells LumiraDx 12-minute COVID test
Oct 26, 2020 9:25am
